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The purpose of the present study was to examine the effects of repeated exposure to local 28 
heat therapy (HT) on skeletal muscle function, myofiber morphology, capillarization and 29 
mitochondrial content in humans. Twelve young adults (23.6±4.8 years, BMI 24.9±3.0 kg/m2) 30 
had one randomly selected thigh treated with HT (garment perfused with water at ~52ºC) for 8 31 
consecutive weeks (90 min, 5 days/week) while the opposite thigh served as a control. Biopsies 32 
were obtained from the vastus lateralis muscle before and after 4 and 8 weeks of treatment. Knee 33 
extensor strength and fatigue resistance were also assessed using isokinetic dynamometry. The 34 
changes in peak isokinetic torque were higher (p=0.007) in the thigh exposed to HT than in the 35 
control thigh at weeks 4 (Control: 4.2±13.1 Nm vs. HT: 9.1±16.1 Nm) and 8 (Control: 1.8±9.7 36 
Nm vs. HT: 7.8±10.2 Nm). Exposure to HT averted a temporal decline in capillarization around 37 
type 2 fibers (p<0.05), but had no effect on capillarization indices in type 1 fibers. The content of 38 
eNOS was ~18% and 35% higher in the thigh exposed to HT at 4 and 8 weeks, respectively 39 
(p=0.003). Similarly, HT increased the content of small heat shock proteins HSPB5 (p=0.007) 40 
and HSPB1 (p=0.009). There were no differences between thighs for the changes in fiber CSA 41 
and mitochondrial content. These results indicate that exposure to local HT for 8 weeks promotes 42 
a pro-angiogenic environment and enhances muscle strength but does not affect mitochondrial 43 
content in humans. 44 
 45 





NEW & NOTEWORTHY  50 
       We demonstrate that repeated application of heat therapy to the thigh using a garment 51 
perfused with warm water enhances the strength of knee extensors and influences muscle 52 
capillarization in parallel with increases in the content of endothelial nitric oxide synthase and 53 
small heat shock proteins. This practical method of passive heat stress may be a feasible tool to 54 
treat conditions associated with capillary rarefaction and muscle weakness. 55 
 56 





 Repeated exposure to whole-body passive heat therapy (HT) in the form of hot water 61 
immersion, sauna, or environmental chambers has been shown to promote a plethora of health 62 
benefits in young individuals (4, 5, 7, 19) as well as in elderly patients with chronic heart failure 63 
(30, 35) and other cardiovascular diseases (20, 34, 36). For example, a recent population-based 64 
study revealed that frequent sauna bathing is associated with a significantly lower risk of fatal 65 
cardiovascular disease events and all-cause mortality (26). The salutary effects of HT are thought 66 
to stem in part from beneficial changes in the cardiovascular system, including improved 67 
endothelial function, reduced arterial stiffness, and blood pressure (4, 5). However, it is 68 
increasingly evident that HT also elicits positive changes in skeletal muscle structure and 69 
function. Treatment with whole-body HT for 6 weeks increased skeletal muscle capillary density 70 
and endothelial cell-specific endothelial nitric oxide synthase (eNOS) content in young 71 
individuals (19). Moreover, as few as eleven days of daily exposure to heat stress in an 72 
environmental chamber improves skeletal muscle contractility, as evidenced by an increase in 73 
evoked peak twitch amplitude and maximal voluntary torque production (32). 74 
 Although whole-body HT modalities have received the greatest attention, emerging 75 
evidence indicates that local HT may also promote skeletal muscle remodeling in humans. Both 76 
superficial (e.g. hot packs, heat wraps, water-circulating garments) and deep tissue (e.g. 77 
shortwave diathermy) local HT modalities are extensively used in rehabilitation settings for the 78 
management of muscle injuries as well as other conditions associated with pain and stiffness (28, 79 
29). Contrary to whole-body HT, heating of a small area or body segment typically induces 80 
minimal or no change in body core temperature. Goto and co-workers first reported that repeated 81 
local thigh heating increased isometric force production of the knee extensors in humans (13). 82 
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Hafen and co-workers reported that short-term heat treatment promotes mitochondrial 83 
adaptations (16) and attenuates immobilization-induced atrophy in human skeletal muscle (15). 84 
We previously demonstrated that a single session of local thigh heating enhances the mRNA 85 
expression of factors associated with vascular growth, including vascular endothelial growth 86 
factor (VEGF) (25). Together, these studies indicate that local HT may be a practical tool to 87 
enhance skeletal muscle mitochondrial content and capillarization and improve contractile 88 
function. Nonetheless, the long-term skeletal muscle adaptations to repeated local heat stress in 89 
humans remain poorly defined.  90 
 The goal of the present study was to comprehensively examine the effects of 8 weeks of 91 
exposure to local HT (5 days/week) on muscle strength, myofiber morphology, capillarization 92 
and mitochondrial content in humans. Healthy young adults had one randomly selected thigh 93 
treated with HT using a water-circulating garment perfused with water at ~52ºC for 90 min, 94 
while the opposite thigh served as a control. This heat modality and protocol were selected 95 
because: 1) a single 90-min session of local HT increases the skeletal muscle expression of heat 96 
shock proteins and angiogenic factors (25); and 2) five daily 90-min sessions of local HT hastens 97 
functional recovery following eccentric exercise-induced muscle damage (22). Based upon these 98 
previous findings, we hypothesized that daily exposure to heat stress would enhance muscle 99 
strength, promote muscle capillary growth and the expression of angiogenic mediators, and 100 





Twelve healthy young adults (10 males, 2 females) volunteered to participate in this 105 
study (mean ± SD: 23.6±4.8 y, 172.9±8.6 cm, 74.5±10.3 kg). Participants were asked to fill out a 106 
health and medical history questionnaire prior to enrollment. Exclusion criteria were: pregnancy, 107 
obesity (body mass index (BMI) > 30 kg/m2), hypertension (resting systolic/diastolic blood 108 
pressure > 140/90 mm Hg), smoking, intake of medications and vitamin supplements, and 109 
history of deep vein thrombosis. Individuals that participated in any kind of supervised physical 110 
activity or engaged in physical activity more than 3 days a week were also excluded. Participants 111 
were informed about risks and discomforts related to the different tests and procedures of the 112 
study before providing their written informed consent to participate. The experimental 113 
procedures adhered to the standards in the latest revision of the Declaration of Helsinki and were 114 
approved by the Institutional Review Board at Purdue University (1604017606). 115 
 116 
Experimental design 117 
 Participants initially visited the laboratory on four separate occasions over a 2-3 week 118 
period. On visits 1 and 2, participants were familiarized with muscle testing on the isokinetic 119 
dynamometer. On visit 3, participants underwent the baseline assessment of muscle strength and 120 
fatigability as described in detailed below. These initial testing sessions were separated by a 121 
minimum of 48 hours. At least one week after visit 3, resting muscle biopsies were collected 122 
from the vastus lateralis of the left and right legs of each subject (22, 25). The 8-week 123 
intervention protocol commenced at least three days after the muscle biopsy procedures. Using a 124 
within-subject design, the legs of participants were assigned in a counterbalanced fashion to 125 
receive HT or no treatment. Participants were asked to report to the laboratory 5 days per week 126 
for a total of 40 sessions. The length of the intervention (8 weeks) was based on the reports by 127 
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Brunt and co-workers that 8 weeks of whole-body HT improves conduit vessel and cutaneous 128 
microvascular function (4, 5). Muscle strength and fatigability were reassessed after 4 and 8 129 
weeks of treatment. These experimental sessions took place approximately 24 hours after the 130 
previous HT session. At least 48 hours after the completion of muscle testing, muscle biopsies 131 
were taken from each thigh. 132 
All visits were conducted in an environmentally controlled laboratory at a similar time of 133 
day. Participants were instructed to fast for 10-11 hours before undergoing muscle biopsies and 134 
to eat a light meal prior to the other experimental visits. Participants were instructed to abstain 135 
from vigorous physical activity in the 24 hours preceding each test and to avoid caffeine 136 
consumption on the day of testing. Participants were asked to maintain their normal dietary and 137 
exercise behavior throughout the study. At the end of each week, participants were asked to self-138 
report the frequency, duration and intensity of physical activity performed in the preceding 5 139 
days. 140 
 141 
Heat treatment 142 
Participants were asked to report at the same time of day for the treatment sessions. Upon 143 
arrival at the laboratory, thermocouples (MLT422; ADInstruments, Colorado Springs, CO) were 144 
taped to both thighs for measurement of skin temperature. Participants were asked to put on 145 
water-circulating trousers on top of shorts or underwear (Med-Eng, Ottawa, Canada). This 146 
garment was customized with an extensive network of medical-grade polyvinyl chloride tubing 147 
that covered the thighs and buttocks (22, 25). In the thigh assigned to receive HT, water at ~52ºC 148 
was perfused through the garment for 90 min with a goal to increase leg skin temperature to 149 ∼39.5–40°C (22, 25). Previous studies that employed a similar approach revealed that this 150 
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regimen causes muscle temperature to increase from a baseline of ~33-34ºC to approximately 151 
37ºC (8, 17).  152 
 153 
Assessment of muscle strength and fatigability 154 
Knee extensor strength and fatigue resistance were assessed using an isokinetic 155 
dynamometer (Humac NORM, Computer Sports Medicine, Inc., Stoughton, MA, USA) as 156 
described previously (22). Participants were familiarized with the testing procedures twice before 157 
the baseline assessment. Participants were seated with hands across the chest, restraining straps 158 
over the trunk, pelvis, and thigh, and the input axis of the dynamometer aligned with the axis of 159 
rotation of the knee. The familiarization protocol included a set of 5-10 concentric knee 160 
extension contractions at 60-70% of the estimated maximal effort at an angular velocity of 161 
180º/s, a set of three maximal contractions at an angular velocity of 180º/s, and a set of 40 162 
consecutive maximal contractions at 180º/s.  163 
On each experimental session, participants were allowed to warm-up for 5 min on a cycle 164 
ergometer and were then positioned on the chair of the isokinetic dynamometer with the identical 165 
apparatus setting predetermined at the first familiarization visit. Testing was performed on both 166 
legs with the order of the testing counterbalanced between participants. Participants were asked 167 
to complete 3 maximal consecutive contractions at 180º/s, with a resting period of 3 min between 168 
limbs. The maximal measured torque (Nm) was used in all analyses. Once both limbs had been 169 
tested for maximal strength, participants were allowed to rest for approximately 3 min and were 170 
then asked to perform a bout consisting of 40 consecutive maximal contractions at 180º/s. A 171 
resting period of 10 min was allowed between limbs. The total work (J) performed during the 172 
bout was computed and used as a measure of fatigue resistance of the knee extensors. The 173 
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investigator that conducted the assessment of muscle function was not blinded to the treatment 174 
assignment. 175 
 176 
Muscle sampling 177 
Muscle biopsies were obtained from the vastus lateralis under local anaesthesia 178 
(Lidocaine hydrochloride, Hospira, Lake Forest, IL) using a 5-mm Bergstrom biopsy needle 179 
(Pelomi Medical, Albruslund, Denmark). The biopsy specimens were promptly weighed, cleared 180 
from visible fat and connective tissue, and divided into three sections. Approximately 40 mg 181 
sections were mounted in transverse orientation in a disposable base mold using an embedding 182 
medium compound (Tissue-tek, O.C.T. compound, Sakura Finetek USA, Torrance, CA) and then 183 
frozen in liquid nitrogen cooled isopentane for cryosectioning. The other sections were 184 
immediately frozen in liquid nitrogen and stored at -80ºC until citrate synthase and Western blot 185 
analysis.  186 
 187 
Immunohistochemistry 188 
Transverse serial sections (10µm) of muscle were cut using a Leica CM1850 cryostat 189 
(Leica, Wetzlar, Germany) at -23°C, mounted on frosted microscope slides (Thermo Scientific, 190 
NH, USA), air-dried for 0.5-1 hours at room temperature, and stored at -80°C for subsequent 191 
analyses. Frozen sections were briefly exposed to room air and fixed with 4% paraformaldehyde 192 
for 5 min. Following 2 x 3 min washes with 1x PBS, the slides were incubated with blocking 193 
buffer (5% goat serum, 2% bovine serum albumin, 0.1% Triton X-100, and 0.1% sodium azide 194 
in PBS) for 1 h at room temperature.  195 
 10
Muscle fiber type distribution was probed using primary antibodies against the basal 196 
lamina and myosin heavy chain (MHC) isoform proteins. Sections were incubated for 3 hours at 197 
room temperature with the following primary antibodies: polyclonal rabbit anti-laminin IgG 198 
(ab11575, 1:500; Abcam), monoclonal mouse anti-MHC I IgG2b (BA-D5, 1:100), monoclonal 199 
mouse anti-MHC IIa IgG1 (A4.74, 1:100), and monoclonal mouse anti-MHC IIx IgM (6H1, 200 
1:100). All MHC primary antibodies were purchased from Developmental Studies Hybridoma 201 
Bank (University of Iowa, IA). After incubation, tissue sections underwent a series of 1× PBS 202 
washes and incubation with fluorescently labeled secondary antibodies for 1 hour at room 203 
temperature: Alexa Fluor 488 goat anti-rabbit IgG (A11008, 1:1000), Alexa Fluor 488 goat anti-204 
mouse IgG2b (A21141, 1:1000), Alexa Fluor 568 goat anti-mouse IgG1 (A21124, 1:1000), and 205 
Alexa Fluor 350 goat anti-mouse IgM (A31552, 1:1000). All secondary antibodies were obtained 206 
from Thermo Fisher Scientific. Following 4 x 5 min washes, slides were briefly dried and 207 
mounted using fluorescent mounting medium (Dako, CA, USA) and the edges were sealed with 208 
nail polish (Sally Hansen Hard as Nails, NY, USA).  209 
Identification of fiber type-specific capillaries was performed in neighboring sections 210 
using antibodies against mouse anti-CD31 IgG1 (550300, 1:100, BD Biosciences), rabbit anti-211 
dystrophin IgG1 (ab15277, 1:100, Abcam) and mouse anti-MHC I (BA-D5, 1:100, DSHB). 212 
After 2 x 5 min washes with 1x PBS, sections were stained with appropriate secondary 213 
antibodies (Alexa 350 goat anti-rabbit IgG, A11609, 1:500; Alexa 488 goat anti-rabbit IgG, 214 
A11008, 1:1000; Alexa 488 goat anti-mouse IgG 2b, A21141, 1:1000; and Alexa 568 goat anti-215 
mouse IgG1, A21124, 1:1000, Thermo Fisher Scientific), diluted in 1x PBS for 1 h at room 216 
temperature. Negative controls for the primary antibodies against CD31 were used to ensure 217 
specificity of staining.  218 
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Slides were viewed at ×20 magnification using an Olympus BX53 fluorescence 219 
microscope equipped with an Olympus DP72 digital camera and cellSens Dimension software. 220 
The entire specimen cross section was initially selected using the stage navigator. The multi-221 
channel image was then acquired and two images from each channel were merged using Image J 222 
software (National Institutes of Health, USA). Histological analysis was not performed in 1 out 223 
of 72 samples due to insufficient muscle yield.  224 
 225 
Analysis of immunofluorescence images 226 
Analyses of immunofluorescence images were carried out using Adobe Photoshop CC 227 
2015. Fiber type distributions were determined from counts of an average of 612 ± 70 muscle 228 
fibers (range 221–1260 fibers). For the quantification of muscle capillarization, all internal fibers 229 
(not bordering on a fascicle) in a cross section were initially counted (an average of 130 ± 23 230 
fibers for type I and 153 ± 26 fibers for type II muscle fibers). A total of 25 type I and 25 type II 231 
muscle fibers were then randomly selected for analysis. Individual fibers were traced to obtain 232 
the area and perimeter of the fiber. Capillaries were quantified using the following indices: (1) 233 
the number of capillaries around a fiber (capillary contacts, CC), (2) the capillary-to-fiber ratio 234 
on an individual fiber basis (C:Fi) and (3) the number of fibers sharing each capillary (sharing 235 
factor, SF), and (4) the capillary to fiber perimeter exchange index (CFPE index), defined as the 236 
C/Fi ratio divided by the fiber perimeter of a given fiber (18). All immunofluorescent images 237 
were blinded for both treatment and time point prior to analysis. 238 
 239 
Protein extraction 240 
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Frozen muscle samples (~30 mg) were homogenized in ice-cold homogenization buffer 241 
containing 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.25% deoxycholic acid, 1% NP-40, 1 mM 242 
EDTA (RIPA Lysis Buffer, EMD Milipore) with freshly added protease inhibitor cocktail 243 
(P8340, Sigma-Aldrich) and phosphatase inhibitors (50 mM NaF and 0.2mM Na3VO4) at a 1:15 244 
dilution of wet muscle weight using a bead mill homogenizer (BEAD RUPTOR12, Omni 245 
International). The resulting homogenate was clarified by centrifugation (13,500 g) for 20 min at 246 
4°C. The supernatant was collected and the protein concentration of each sample (~5 µg/µL) was 247 
determined with a BCA protein assay kit (Thermo Scientific, IL, USA). All samples were 248 
subsequently diluted with homogenization buffer (1.5 µg/µL) and subsequently mixed with 249 
either reducing sample buffer (4x Laemmli sample buffer with 10% 2-Mercaptoethanol) or non-250 
reducing sample buffer (4x Laemmli sample buffer). Afterwards, samples were heated to 95ºC 251 
for 5 min (except for mitochondrial OXPHOS protein blots), divided into small aliquots, and 252 
stored at -80ºC. 253 
 254 
Western blot analysis 255 
For the analysis of HSP90A, HSP90B, VEGF, ANGPT1, p-eNOSser1177, eNOS, and 256 
OXPHOS, 20 μg of protein were separated by SDS-PAGE on precast Stain Free 4-15 % gels 257 
(Bio-Rad, CA, USA) and transferred to polyvinylidene fluoride (PVDF) membranes using the 258 
Trans-Blot® Turbo transfer system (Bio-Rad, CA, USA). Membranes were subsequently 259 
blocked with 5 % non-fat milk in 1x TBST (1% tween 20) solution for 1 h at room temperature 260 
(~23°C) and incubated for 3-4 hours at room temperature with primary antibodies diluted in 261 
blocking buffer. The membranes were washed with 1x TBST at room temperature for 3 x 10 262 
min, incubated with horseradish peroxidase-conjugated secondary antibodies diluted in 1x TBST 263 
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for 1 h at room temperature and were then washed with 1x TBST at least 3 x 10 min before being 264 
exposed to an enhanced chemiluminescent solution (Clarity Western ECL, Bio-Rad, USA) for 265 
5 min. Membranes were visualized using a densitometer (ChemiDoc Touch Imaging System, 266 
Bio-Rad, USA), and band densities were determined using image-analysis software (Image Lab 267 
V6.0.1, Bio-Rad, USA). PageRuler Prestained Protein Ladder (Thermo Fisher, USA) was used 268 
as a molecular weight marker. Control for equal loading was performed using the stain-free 269 
technology and total protein normalization was used to calculate changes in the expression of 270 
each target protein relative to the baseline sample. The analysis of HSPB5, HSPB1, HSPA1A 271 
was performed as described previously (11). Details of the primary antibodies are provided in 272 
Supplemental Table S1 (https://figshare.com/articles/Supplemental_Table_S1_docx/11385921) 273 
https://doi.org/10.6084/m9.figshare.11385921. Recombinant proteins were used to confirm 274 
antibody specificity.  275 
 276 
Citrate synthase activity 277 
The maximal enzyme activity of citrate synthase (CS) was determined using the lysate 278 
prepared for Western blot analyses and analyzed on a spectrophotometer (Bio-Rad). Samples 279 
were analyzed in triplicate and each well (final reaction volume 210 µL, pathlength 0.57 cm) 280 
contained 10 µL of ~2 mg/ml lysate, 0.3 mM acetyl-CoA, 0.15 mM 5,5'-Dithiobis 2-nitrobenzoic 281 
acid (DTNB), 0.25% w/v Triton-X, and 1 mM oxaloacetate made to volume with 100 mM Tris 282 
buffer, pH 8.3. Oxaloacetate was added to commence the reaction, which was measured by 283 
change in absorbance (DTNB ɛ = 14150 M-1.cm-1 at 412 nm) every 15 s over a 3-min period at 284 
25ºC then enzyme activity was expressed as nanomoles per minute per milligram of protein. 285 
  286 
 14
Statistical analysis  287 
 All statistical analyses were conducted using SAS (Version 9.4; SAS Institute, Cary, NC) 288 
with results expressed as means ± SD. The Kolmogorov-Smirnov test was used to assess the 289 
distribution of the data. Data exhibiting skewed distribution (HSPB5, HSPB1, p-eNOS, 290 
ANGPT1, HSP90A, HSP90B) were log-transformed before statistical analysis. Descriptive 291 
results for each variable are expressed as means ± SD, or geometric mean ×/÷ geometric standard 292 
error if the variable value was log-transformed. A two-way repeated measures ANOVA was 293 
employed to compare the changes from baseline in all variables between the leg exposed to HT 294 
and the control leg. A Tukey post-hoc analysis was performed when appropriate. For all 295 
analyses, P < 0.05 was considered statistically significant.  296 
 297 
RESULTS 298 
Thigh skin temperature 299 
 Figure 1 displays the temporal profile of thigh skin temperature during exposure to 90 300 
min of HT or the control regimen. The average temperature in the thigh assigned to receive HT 301 
was 39.8±0.3ºC, while in the control leg the average temperature was 32.4±0.3ºC (main 302 
treatment effect, p<0.001). 303 
 304 
Muscle strength and fatigability 305 
 In the thigh that received HT, maximal isokinetic peak torque of the knee extensors at 306 
180º/s improved by 6% at week 4 and by 5% on week 8 (baseline: 140±40 Nm, 4 weeks: 149±50 307 
Nm, 8 weeks:148±46 Nm) (Figure 2). Conversely, in the control thigh, peak torque increased by 308 
2% and 1% at weeks 4 and 8, respectively (baseline: 142±43 N, 4 weeks: 147±44 N, 8 weeks: 309 
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144±45 N). Comparison of the changes from baseline in peak torque revealed a significant main 310 
effect of treatment (p=0.007), but no time effect (p=0.333) or treatment × time interaction 311 
(p=0.778). Fatigability, as assessed by the total work completed during 40 consecutive maximal 312 
contractions at 180º/s, was not altered after exposure to either HT (baseline: 4434±1232 J, 4 313 
weeks: 4404±1310 J, 8 weeks: 4449±1281 J) or in the control thigh (baseline: 4309±1122 J, 4 314 
weeks: 4400±1286 J, 8 weeks: 4321±1153 J) (Figure 2). 315 
 316 
Fiber type distribution and morphology 317 
 Muscle fiber cross-sectional area (CSA), perimeter, SF as well as fiber type distribution 318 
are shown on Table 2. There were no treatment, time or treatment x time effects for the changes 319 
in fiber cross-sectional area in both fiber types. Fiber type distribution was also not significantly 320 
influenced by HT.  321 
 322 
Capillarization 323 
 The number of capillary contacts in type 1 fibers declined throughout the study in both 324 
the control thigh (baseline: 5.0±1.1, 4 weeks: 4.7±0.8, 8 weeks: 4.8±0.8) and in the thigh treated 325 
with HT (baseline: 5.1±1.0, 4 weeks: 4.7±0.8, 8 weeks: 4.7±0.8) (Figure 3). Exposure to HT also 326 
had no significant effect on other capillarization indices in type 1 fibers (Figure 3). Conversely, 327 
while the number of capillary contacts around type 2 fibers declined by nearly 10% in the control 328 
thigh (baseline: 4.6±0.6, 4 weeks: 4.2±0.7, 8 weeks: 4.2±0.5), exposure to HT prevented a 329 
temporal reduction in this variable (baseline: 4.2±0.6, 4 weeks: 4.2±0.6, 8 weeks: 4.3±0.8). A 330 
significant treatment effect was observed for the changes in capillary contacts (p=0.016), the 331 
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capillary-to-fiber ratio on an individual fiber basis (p=0.007), and the capillary-to-fiber perimeter 332 
exchange index (p<0.001) in type 2 fibers (Figure 3). 333 
 334 
Mitochondrial content 335 
 The changes in maximal citrate synthase activity and the content of OXPHOS protein 336 
complexes are shown on Table 2. There were no treatment, time, or treatment x time interaction 337 
for levels of the mitochondrial OXPHOS proteins measured.  338 
 339 
Expression of angiogenic factors and heat shock proteins 340 
 A main effect of treatment was observed for the changes in skeletal muscle eNOS content 341 
(p=0.003), while eNOS ser1177 phosphorylation (p=0.389) and eNOS phosphorylation normalized 342 
to eNOS content (p=0.201) were not altered by the intervention (Figure 6). The protein content 343 
of members of the small heat shock protein (HSP20) family, alpha B-crystallin (HSPB5) (main 344 
effect of treatment, p=0.007) and heat shock protein family B member 1 (HSPB1) (main effect of 345 
treatment, p=0.009), were also significantly higher in the thigh treated with HT (Figure 6). No 346 
treatment effect was observed for the changes in VEGF, ANGPT1, HSPA1A and the HSP90 347 
family members (Figure 6).  348 
 349 
DISCUSSION 350 
 The primary findings of this study were that repeated local thigh heating for 8 weeks 351 
elicited an increase in eNOS content and averted a temporal decline in skeletal muscle 352 
capillarization indices. Conversely, HT had no effect on skeletal muscle mitochondrial content. 353 
Confirming earlier observations that exposure to local and whole-body heat stress improves 354 
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skeletal muscle contractile function (13, 32), we also report that 8 weeks of local HT enhanced 355 
the strength of the knee extensors. Combined, these findings indicate that a simple and well-356 
tolerated HT modality significantly influences skeletal muscle morphology and function and 357 
sheds new light on the potential therapeutic use of local heat stress to treat conditions associated 358 
with skeletal muscle abnormalities. 359 
 360 
Experimental considerations 361 
We chose to apply local HT for 90 min in each session in the present study because we 362 
previously showed that this regimen elicits increased expression of heat shock proteins and 363 
angiogenic mediators in human skeletal muscle (25). Thus, participants were required to spend 364 
90 min daily (5 days/week) sitting in the laboratory to receive HT and control treatments. One 365 
unintended consequence of this demanding protocol was that some participants reported being 366 
unable to maintain their habitual exercise routines throughout the study due to time constraints. 367 
Although we did not directly measure physical activity patterns, analysis of weekly reports by 368 
the participants revealed that seven individuals had marked decrements in exercise time 369 
throughout the study, while three others reported modest changes. The reduction in structured 370 
physical activity coupled with increased sedentary time might be partially responsible for the 371 
observed small, albeit consistent, decline in fiber cross-sectional area (Table 2) and 372 
capillarization (Figure 3), particularly in the thigh assigned to the control regimen. Several 373 
studies have shown that short periods of reduced physical activity (e.g. step reduction) impairs 374 
glucose metabolism, including insulin sensitivity (24) and lowers myofibrillar protein synthesis 375 
rates (33) in healthy young adults. More severe forms of muscle disuse, such as 2 weeks of 376 
single leg limb immobilization, lead to reduced leg lean mass and muscle capillarization in old 377 
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and young men (39). Of note, exposure to HT has been shown to attenuate the manifestations of 378 
skeletal muscle disuse in animals (37, 58) as well as in humans (15). Our findings that daily local 379 
HT prevented the decline and/or enhanced indices of capillarization (Figure 3) relative to the 380 
control intervention add to this growing body of literature that indicates that HT mitigates the 381 
detrimental consequences of physical inactivity in skeletal muscle. 382 
 383 
Effect of HT on muscle capillarization 384 
 The ability of heat stress to promote a pro-angiogenic milieu in skeletal muscle and a 385 
consequent increase in capillarization was first documented by Akasaki and co-workers in a 386 
model of peripheral arterial insufficiency (1). These authors showed that mice treated with far-387 
infrared dry sauna daily for 5 weeks had greater capillary density and eNOS expression in the 388 
ischemic muscle. Of note, chronic treatment with NOS inhibitor N(ω)-nitro-L-arginine methyl 389 
ester (L-NAME) abolished the changes in capillarization as well as the recovery in blood flow 390 
(1). Similarly, the angiogenic response to heat stress was absent in mice lacking eNOS (1). 391 
Recently, these earlier observations in ischemic mouse skeletal muscle were extended to humans. 392 
Hesketh and co-workers reported that 6 weeks of whole-body passive HT increased capillary 393 
density by 21% and endothelial-specific eNOS content by 8% in the vastus lateralis muscle of 394 
sedentary young individuals (19). The increase in eNOS content and the consequent angiogenic 395 
response to whole-body HT appears to be mediated in part by circulating factors. Brunt and co-396 
workers showed that exposing cultured endothelial cells to serum collected from participants 397 
who had undergone whole-body HT for 8 weeks increased the abundance of eNOS and 398 
endothelial tubule formation (6). Combined, these studies provide compelling evidence 399 
implicating nitric oxide (NO) as a critical mediator of heat-induced skeletal muscle angiogenesis. 400 
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 Based upon these earlier reports, we examined the effects of local HT on the content of 401 
eNOS and muscle capillarization. In accordance with the previous findings from whole body 402 
heating (19), we report that eNOS content was 18% and 35% higher in the thigh exposed to HT 403 
as compared to the control thigh at 4 and 8 weeks, respectively (Figure 6). Changes in eNOS 404 
were accompanied by significant differences in capillarization between HT and control in type 2, 405 
but not type 1 fibers (Figure 3). The mechanistic basis underlying the fiber type specific effect of 406 
HT on capillarization is unclear. Increased wall shear stress in the capillary network has been 407 
proposed to be a critical signal for promoting HT-induced skeletal muscle angiogenesis (1, 19). 408 
Studies in animals (2) as well in humans (17) have documented a modest increase in muscle 409 
blood flow during exposure to local heat stress. It is possible to speculate that type 2 fibers 410 
experienced a greater relative increase in blood flow (and wall-shear stress) during HT compared 411 
to type 1 fibers. Alternatively, it is possible that the effects of HT were mostly evident in type 2 412 
fibers because capillarization around these fibers was more severely impacted by reduced 413 
physical activity levels (Figure 3). Of note, Hesketh and co-workers did not observe differences 414 
between fiber types in the magnitude of the increase in capillarization following 6 weeks of 415 
whole-body HT (19). 416 
Contrary to our hypothesis, we did not observe changes in the content of VEGF and 417 
ANGPT1 levels after treatment with local HT. We previously reported that the expression of 418 
these pivotal angiogenic mediators is enhanced following a single session (25) as well as 5 days 419 
of repeated exposure to HT in injured muscle (22). It is plausible that the levels of these factors 420 
were temporarily increased early in the intervention period and later declined toward baseline 421 
levels. A similar scenario might explain the lack of effect of local HT on the content of several 422 
members of the heat-shock protein family, including HSP70 and HSP90. One important 423 
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exception was the marked increase in the content of small heat-shock proteins HSPB5 and 424 
HSPB1 in the thigh exposed to HT (Figure 6). This is an important observation because small 425 
heat shock proteins have been implicated in the regulation of angiogenesis and blood vessel 426 
function in multiple tissues (10, 21). Additional studies are warranted to define the role these 427 
molecular chaperones exert on heat-induced skeletal muscle angiogenesis. 428 
 429 
Heat stress and mitochondrial biogenesis 430 
 The finding that heat stress induces mitochondrial biogenesis in C2C12 myotubes (27) 431 
has led to several investigations asking if repeated HT could potentially enhance mitochondrial 432 
content in vivo. Experiments in mice revealed that daily exposure to whole body heat stress (5 433 
days/wk for 3 wk) increased mitochondrial enzyme activities and respiratory chain protein 434 
content in skeletal muscle (38). More recently, local heating of the vastus lateralis for 6 435 
consecutive days (2 h daily) increased mitochondrial respiratory capacity and mitochondrial 436 
content (16). In contrast, we did not observe a significant effect of local HT on the content of 437 
respiratory chain proteins or maximal CS activity in the present study. Our findings align closely 438 
with the recent report of Hesketh and co-workers that repeated whole-body HT had no effect on 439 
skeletal muscle mitochondrial density despite marked effects on exercise capacity and 440 
capillarization (19). The inconsistent effect of HT on mitochondrial content may be partially 441 
explained by variations in the magnitude and duration of heat stress as well as the modality used 442 
for heat induction in skeletal muscle. Pulsed shortwave diathermy, which produces rapid and 443 
marked deep tissue heating (12), may be more effective at producing mitochondrial adaptations 444 
than superficial heat modalities as employed in the current report. It is worth noting that we have 445 
not measured the content of AMP-activated protein kinase (AMPK), peroxisome proliferator-446 
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activated receptor gamma, coactivator-1 alpha (PGC1a) and other biomarkers of mitochondrial 447 
biogenesis nor assessed the effects of HT on mitochondrial respiration. Hafen and co-workers 448 
showed that despite no changes in citrate synthase activity, a common surrogate marker of 449 
mitochondrial content, local HT using diathermy increased the content of PGC1a and the 450 
phosphorylation of AMPK and resulted in improved mitochondrial respiratory capacity (16). 451 
 452 
HT and skeletal muscle strength 453 
 Given that local heat treatment of the thigh for 8 h/day for 10 weeks improved maximal 454 
isometric force in young individuals (13), we questioned if 90 min of thigh heating over 8 weeks 455 
would significantly enhance knee extensor strength. In agreement with the findings of Goto and 456 
co-workers (13), maximal isokinetic torque increased to a greater extent in the thigh exposed to 457 
HT as compared to the control thigh with just 90 min of treatment (Figure 2). This improvement 458 
in force after treatment with local HT occurred despite no significant differences in fiber cross-459 
sectional area between treatments (Table 2), indicating that adaptations other than changes in 460 
fiber size explain the observed improvements in force generating capacity. Of note, Racinais and 461 
colleagues demonstrated that as little as 11 days of whole-body heat stress increased peak twitch 462 
amplitude and torque production of the plantar flexors in humans (32). As it seems unlikely that 463 
major changes in fiber size would occur in this short period of time, these findings imply that 464 
alternative mechanisms, including increases in force per cross-bridge or possibly the kinetics of 465 
formation of cross-bridges contribute to strength gains to heat therapy (32). Of note, the study of 466 
Racinais et al did not include a sham-treated group and it is thus impossible to exclude the 467 
possibility that the improvement in muscle function derived partially from a time and/or 468 
familiarization effect (32). Further research is needed to explore the mechanistic basis of 469 
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enhanced force-generating capacity of muscles exposed to repeated heat stress. Additional 470 
studies are also warranted to define if in addition to muscle strength, HT may affect muscle 471 
power and improve performance during submaximal, prolonged events. 472 
 473 
Limitations 474 
 An important limitation of the current study is that we have not directly measured 475 
intramuscular temperature during exposure to local HT. Studies that employed water-circulating 476 
garments perfused with warm water to heat the calf or the entire leg of healthy individuals 477 
reported average increases in intramuscular temperature ranging from 2.5 to 4ºC (8, 17). As we 478 
utilized a similar heating modality and treatment regimen, it is tempting to suggest that 479 
comparable changes in temperature occurred in the present study. Nonetheless, it worth 480 
highlighting that the time course and magnitude of changes in muscle temperature upon exposure 481 
to heat treatment may be modulated by a number of factors, including the treatment duration and 482 
the thickness of the subcutaneous fat layer (31).  483 
 Another limitation that is inherent to HT studies is the fact that participants cannot be 484 
blinded to the intervention. This imposes a challenge for the interpretation of experimental 485 
outcomes that are prone to the placebo effect, including voluntary force production. It is 486 
plausible that the observed increase in muscle strength after treatment with HT may be partially 487 
ascribed to a placebo effect. This seems unlikely given the accumulating evidence derived from 488 
animal studies that repeated heat stress enhances muscle strength and prevents disuse-induced 489 
muscle weakness. For instance, we recently reported that repeated immersion in a water bath at 490 
37°C and 39°C for 3 weeks enhanced maximal absolute force of the soleus muscle in a model of 491 
ischemia-induced muscle damage (23). Similarly, Yoshihara and colleagues reported that 3 days 492 
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of whole-body HT using a heat chamber (40-41°C for 60 min) abrogated ventilator-induced 493 
diaphragm contractile dysfunction in rats (40). These findings reveal that repeated heat stress 494 
elicits adaptations that culminate in an improved force generation capacity. Nonetheless, it is 495 
imperative that future studies in humans compare the effects of HT on muscle force with a 496 
placebo rather than a control intervention (3).  497 
 498 
Clinical implications 499 
Water-circulating garments are amenable for home use, do not require supervision by a 500 
therapist, and are practical for individuals with restricted locomotion who cannot participate in 501 
exercise (e.g. severe peripheral artery insufficiency, chronic heart failure and chronic obstructive 502 
pulmonary disease). Our findings that local HT enhances muscle strength and affects muscle 503 
capillarization indicate that this method may be a feasible tool to treat these chronic conditions. 504 
One caveat regarding the clinical use of tube-lined garments for HT is that this modality is 505 
designed primarily to manipulate skin temperature (9). Prolonged exposure to this method is 506 
necessary to attain significant increases in intramuscular temperature (8). For example, 1 hr of 507 
perfusion of 50°C water through a garment covering a single leg raised the vastus lateralis 508 
muscle temperature by ~2.5ºC (8). Substantially faster and greater increases in intramuscular 509 
temperatures can be achieved with the use of deep tissue heating modalities, such as short-wave 510 
diathermy. Garrett and co-workers showed that diathermy application for 20 min raised the 511 
triceps surae muscle temperature by ~3.5ºC (12). Deep tissue heating modalities may therefore 512 
possibly confer benefits that are similar or superior to the ones reported herein despite a 513 
substantially lower treatment duration. It should be emphasized, nonetheless, that diathermy is 514 
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less accessible than superficial heating modalities because these devices are expensive, 515 
cumbersome and require a trained professional for proper operation. 516 
In addition to its use in rehabilitation, there is evidence that HT may be an ergogenic aid 517 
to boost the adaptations to exercise training. For example, Tamura and co-workers recently 518 
showed that post-exercise whole body heat stress (40°C, 30 min/day, 5 days/wk, 3 wk) additively 519 
enhanced endurance training-induced mitochondrial adaptations in mouse skeletal muscle (38). 520 
Goto and co-workers showed that repeated heating of the elbow flexor muscles using a heating 521 
and steam-generating sheet prior to and during low-load resistance exercise resulted in greater 522 
changes in maximum isometric torque and cross-sectional area of the biceps brachii muscle as 523 
compared to resistance training alone (14). This effect of HT does not appear to occur in the 524 
lower-limb muscles. Stadnyk and colleagues recently reported local thigh heating during, and for 525 
20 min after resistance exercise of the knee extensors in untrained individuals had no effect on 526 
training-induced hypertrophy or function (37). It remains to be determined whether HT may 527 
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FIGURE LEGENDS 674 
 675 
Figure 1: Thigh skin temperature during exposure to 90 min of heat therapy (HT, closed circles) 676 
or the control intervention (open circles). Data were analyzed with a 2-way repeated-measures 677 
ANOVA. Values are means ± SD. *p < 0.05 vs. Control.  678 
 679 
Figure 2: Individual and group mean changes from baseline in muscle strength (A) and fatigue 680 
resistance (B) following 4 and 8 weeks of heat therapy (HT, closed squares) or the control 681 
intervention (open squares). Data were analyzed with a 2-way repeated-measures ANOVA. 682 
*main effect of treatment (p < 0.05).   683 
 684 
Figure 3: A: Representative skeletal muscle cross section displaying immunoreactivity for 685 
dystrophin (blue), CD31 (red), and myosin heavy chain type I (green). B and C: Changes from 686 
baseline in the number of capillary contacts (CC) for type I (B) and type II (C) fibers. D and E: 687 
Changes from baseline in the number of capillaries to each muscle fiber (C:Fi) for type I (D) and 688 
type II (E) fibers. F and G: Changes from baseline in the capillary-to-fiber perimeter exchange 689 
index (CFPE) for type I (F) and type II (G) fibers.  Data were analyzed with a 2-way repeated-690 
measures ANOVA. *main effect of treatment (p < 0.05).  691 
 692 
Figure 4: Fold changes in skeletal muscle protein expression relative to the baseline sample of 693 
select stress management and angiogenic proteins. A: Endothelial nitric oxide synthase (eNOS). 694 
B: Phosphorylated endothelial nitric oxide synthase at Ser1177 (p-eNOS ser1177). C: The ratio of 695 
p-eNOSser1177 to eNOS. D: Alpha B-crystallin protein (HSPB5). E: Heat shock protein family B 696 
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member 1 (HSPB1). F: Vascular endothelial growth factor (VEGF). G: Angiopoietin 1 697 
(ANPTT1). H: Heat shock protein 72-kDa (HSPA1A). I: Heat shock protein 90-kDa alpha class 698 
A member 1 (HSP90A). J: Heat shock protein 90-kDa alpha class B member 1 (HSP90B). The 699 
baseline sample was assigned a value of 1 and is represented by the dashed line. Data exhibiting 700 
skewed distribution (HSPB5, HSPB1, p-eNOS, ANGPT1, HSP90A, HSP90B) were log-701 
transformed before statistical analysis. Values are means ± SD or geometric mean ×/÷ geometric 702 
standard error if the variable value was log-transformed. Data were analyzed with a 2-way 703 
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Table 1. Muscle fiber morphological measurements  
    Control   Heat therapy 
  Week 0 Week 4 Week 8 Week 0 Week 4 Week 8 
Type I CSA, µm2  6013.3±1136.4 -20.3±1202.2 -533.5±1193.2 6394.2±1608.9  -431.9±1717.7 -315.5±2234.2 
Type II CSA, µm2 7186.8±1168.2  -443.9±1638.6 -1192.3±1958.7 6960.6±1208.1 -488.6±2141.1 -564.3±1934.0 
Type I perimeter, µm 326.2±28.1  7.3±34.0 -11.7±33.5  339.2±42.7 -18.4±37.5 -6.2±67.7 
Type II perimeter, µm 367.4±60.9  -14.2±59.9 -35.7±67.9  359.0±35.7 -23.7±44.9 -17.8±62.6 
Type I SF 2.53±0.2  -0.06±0.3 0.07±0.2 2.62±0.1 0.02±0.1 -0.10±0.2 
Type II SF 2.58±0.2 -0.03±0.3 0.05±0.2 2.59±0.2 0.05±0.2 -0.06±0.3 
Type I (%) 38.4±6.1  -2.01±8.9 -1.45±5.3 42.5±14.0 -3.82±9.0 -2.73±12.2 
Type II (%)   61.6±6.1  2.01±8.9 1.45±5.3  57.5±14.0 3.82±9.0 2.73±12.2 
Values are means ± SD; Week 0, baseline values prior to treatments; Week 4 and week 8, changes from baseline value following 4 




Table 2. Changes in maximal citrate synthase activity and the content of OXPHOS protein complexes   
    Control   Heat therapy 
 Week 4 Week 8 Week 4 Week 8 
Maximal citrate synthase activity 
(nmol/min/mg protein) -4.40±14.43 2.04±11.43 -0.84±6.83 -2.94±14.05 
Fold changes in OXPHOS protein complexes     
Complex I 1.03±0.35 1.11±0.54 0.98±0.26 1.08±0.33 
Complex II 0.89±0.30 0.96±0.38 0.90±0.28 0.93±0.33 
Complex III 1.06±0.15 1.06±0.21 1.02±0.11 1.03±0.13 
Complex IV 1.02±0.36 1.10±0.46 0.92±0.23 0.97±0.44 
Complex V  1.01±0.17 1.02±0.22  0.99±0.15 1.01±0.18 
Values are means ± SD; Week 4 and week 8, changes from baseline value following 4 and 8 weeks of heat therapy or control 
intervention 
 
  
 
